Raised liver enzyme in a patient receiving Helicobacter pylori triple regimen: A case report

infection remains a worldwide spread disease with a definitemorbidity and mortality.Indeed, this infection is the main cause of non-ulcer dyspepsia, peptic ulcers and gastric tumors, including bothlow-grade MALT-lymphoma and adenocarcinoma. A 65-year-old female patient visited outpatient department of Gastroenterology clinic for a routine follow-up after completion of 14-day triple drug therapy for . After a few days of empirical treatment for raised liver enzymes, her liver enzymes normalized. Clinicians should be aware about the rare adverse event during eradication treatment.
 

Keywords: H. pylori, Liver function, Liver enzymes